Indian vaccine makers tap Rs 900 crore government funding scheme

India’s top vaccine makers have approached the department of biotechnology (DBT) seeking support under the ₹900 crore Covid Suraksha Fund to accelerate their vaccine development programmes.Announcement of the first round of funding is expected this week, and Biological E and Gennova are likely to receive up to ₹100 crore in this round, people in the know said. Other vaccine makers that have applied for the grant include Serum Institute of